These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26628874)

  • 1. Physician preferences for bone metastasis drug therapy in Canada.
    Arellano J; González JM; Qian Y; Habib M; Mohamed AF; Gatta F; Hauber AB; Posner J; Califaretti N; Chow E
    Curr Oncol; 2015 Oct; 22(5):e342-8. PubMed ID: 26628874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom.
    Qian Y; Arellano J; Gatta F; Hechmati G; Hauber AB; Mohamed AF; Bahl A; von Moos R; Body JJ
    BMC Health Serv Res; 2018 Jul; 18(1):518. PubMed ID: 29970078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom.
    Hechmati G; Hauber AB; Arellano J; Mohamed AF; Qian Y; Gatta F; Haynes I; Bahl A; von Moos R; Body JJ
    Support Care Cancer; 2015 Jan; 23(1):21-8. PubMed ID: 24939674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' preferences for bone metastases drug therapy in the United States.
    Arellano J; Hauber AB; Mohamed AF; Gonzalez JM; Collins H; Hechmati G; Gatta F; Qian Y
    Value Health; 2015 Jan; 18(1):78-83. PubMed ID: 25595237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors.
    Qian Y; Arellano J; Hauber AB; Mohamed AF; Gonzalez JM; Hechmati G; Gatta F; Harrelson S; Campbell-Baird C
    Patient; 2016 Aug; 9(4):323-33. PubMed ID: 26821359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences for treatments to delay bone metastases.
    Hauber AB; Arellano J; Qian Y; González JM; Posner JD; Mohamed AF; Gatta F; Tombal B; Body JJ
    Prostate; 2014 Nov; 74(15):1488-97. PubMed ID: 25132622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.
    Mansfield C; Sikirica MV; Pugh A; Poulos CM; Unmuessig V; Morano R; Martin AA
    Diabetes Ther; 2017 Dec; 8(6):1365-1378. PubMed ID: 29101681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes.
    Hauber AB; Nguyen H; Posner J; Kalsekar I; Ruggles J
    Curr Med Res Opin; 2016; 32(2):251-62. PubMed ID: 26549576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries.
    von Moos R; Body JJ; Rider A; de Courcy J; Bhowmik D; Gatta F; Hechmati G; Qian Y
    J Bone Oncol; 2018 Jun; 11():1-9. PubMed ID: 29892519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16).
    Mark M; Thürlimann B; Ribi K; Schär C; Dietrich D; Cathomas R; Zürrer-Härdi U; von Briel T; Anchisi S; Bohanes P; Blum V; von Burg P; Mannhart M; Caspar CB; von Moos R
    J Bone Oncol; 2020 Apr; 21():100273. PubMed ID: 31970055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. German travelers' preferences for travel vaccines assessed by a discrete choice experiment.
    Poulos C; Curran D; Anastassopoulou A; De Moerlooze L
    Vaccine; 2018 Feb; 36(7):969-978. PubMed ID: 29338877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
    Eliasson L; de Freitas HM; Dearden L; Calimlim B; Lloyd AJ
    Clin Ther; 2017 Apr; 39(4):723-737. PubMed ID: 28366592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and parent preferences for immunoglobulin treatments: a conjoint analysis.
    Mohamed AF; Kilambi V; Luo MP; Iyer RG; Li-McLeod JM
    J Med Econ; 2012; 15(6):1183-91. PubMed ID: 22846048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany.
    Poulos C; Kinter E; Yang JC; Bridges JF; Posner J; Gleißner E; Mühlbacher A; Kieseier B
    Ther Adv Neurol Disord; 2016 Mar; 9(2):95-104. PubMed ID: 27006697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding Treatment Strategies and Preferences in Nonmetastatic Castration-Resistant Prostate Cancer From the Japanese Physician Perspective.
    Suzuki K; Grillo V; Chen Y; Singh S; Ledesma DA
    JCO Glob Oncol; 2021 Feb; 7():302-310. PubMed ID: 33617305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician preferences for medication attributes for the prophylactic treatment of patients with severe haemophilia A with inhibitors to factor VIII.
    Gelhorn H; Merikle E; Krishnan S; Nemes L; Leissinger C; Valentino L
    Haemophilia; 2013 Jan; 19(1):119-25. PubMed ID: 23005041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' priorities in selecting chronic lymphocytic leukemia treatments.
    Mansfield C; Masaquel A; Sutphin J; Weiss E; Gutierrez M; Wilson J; Boeri M; Li J; Reyes C
    Blood Adv; 2017 Nov; 1(24):2176-2185. PubMed ID: 29296865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
    Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
    Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study.
    Poulos C; Wakeford C; Kinter E; Mange B; Schenk T; Jhaveri M
    Mult Scler J Exp Transl Clin; 2020; 6(1):2055217320910778. PubMed ID: 32215218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.